80
Participants
Start Date
April 15, 2025
Primary Completion Date
October 15, 2025
Study Completion Date
October 30, 2025
Pentoxifylline 400 MG Oral Tablet
Oral tablet, 400 mg, administered twice daily with food for 6 months. To be taken in addition to conventional medications for chronic kidney disease.
Conventional Medications for Chronic Kidney Disease
This arm receives conventional medical management for chronic kidney disease (CKD). This includes medications and treatments as deemed necessary and appropriate by the participant's treating physician, according to established clinical guidelines for CKD. These may include, but are not limited to, medications for blood pressure control, management of diabetes, anemia treatment, mineral and bone disorder management, and fluid and electrolyte balance management. The specific medications and treatments are individualized and not dictated by the study protocol, but follow standard clinical practice for CKD.
Mansoura University
OTHER